For example, SIRT3 expression was significantly down-regulated in prostate cancer (PC), and it restrained the EMT and migration of PC cells through inactivating the promoted FOXO3A-mediated Wnt/β-catenin pathway [36]. This evidence concerns the gene FOXO3 and prostate carcinoma.